Does neutrophil-to-lymphocyte ratio predict 1-year mortality in patients with primary biliary cholangitis? Results from a retrospective study with validation cohort.
Does neutrophil-to-lymphocyte ratio predict 1-year mortality in patients with primary biliary cholangitis? Results from a retrospective study with validation cohort.
复制标题
中性粒细胞与淋巴细胞比率能否预测原发性胆汁性胆管炎患者的 1 年死亡率?
DOI:
10.1136/bmjopen-2016-015304
复制
发表时间:
2017-07-12
期刊:
影响因子:
2.9
通讯作者:
Sun C
中科院分区:
文献类型:
--
作者:
Lin L;Piao M;Jiang X;Lv H;Zhao N;Yang F;Sun C
Objectives Neutrophil-to-lymphocyte ratio (NLR) has been used to predict prognosis in various liver diseases, but its role in primary biliary cholangitis (PBC) is not clarified. We aimed to investigate the prognostic usefulness of NLR for 1-year mortality in PBC. Methods The study recruited a retrospective cohort with 88 patients with PBC and a prospective validation cohort with 63 participants who were followed-up for 1 year. NLR and other laboratory measurements were analysed by multivariate regression model for identifying independent factors for early mortality. The cut-off threshold of NLR was determined by calculating the area under the receiver operating characteristics curve (AUROC) and used in a subsequent Kaplan-Meier survival analysis. Results Univariate and multivariate analyses showed that Mayo Risk Score (MRS), serum creatinine and NLR were independent indicators for mortality. NLR yielded significantly higher AUROC (0.86) than those of platelet-to-lymphocyte ratio (0.58, p=0.03), but comparable with MRS (0.87, p=0.88). Spearman’s correlation analysis represented a positive correlation between escalating NLR and aggravating Child-Pugh grade (r=0.44, p<0.001). Patients with NLR <2.18 exhibited higher survival (with 100% sensitivity and 67.1% specificity) within 1 year follow-up duration, and NLR ≥2.18 was indicative of higher mortality (log-rank test, p<0.001). In addition, these results were internally confirmed by a validation cohort. Conclusion NLR is closely related to short-term mortality in patients with PBC.
登录
查看更多内容
影响因子:
--
作者:
Grosse-Steffen T;Giese T;Giese N;Longerich T;Schirmacher P;Hänsch GM;Gaida MM
通讯作者:
Gaida MM
影响因子:
3.8
作者:
Oh BS;Jang JW;Kwon JH;You CR;Chung KW;Kay CS;Jung HS;Lee S
通讯作者:
Lee S
影响因子:
3.7
作者:
Xue TC;Zhang L;Xie XY;Ge NL;Li LX;Zhang BH;Ye SL;Ren ZG
通讯作者:
Ren ZG
DOI:
10.1002/lt.24702
发表时间:
2017-03
期刊:
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
影响因子:
--
作者:
Kalra A;Wedd JP;Bambha KM;Gralla J;Golden-Mason L;Collins C;Rosen HR;Biggins SW
通讯作者:
Biggins SW
影响因子:
20.3
作者:
Schwaller, Juerg;Schneider, Pascal;Huard, Bertrand
通讯作者:
Huard, Bertrand